Detalhe da pesquisa
1.
Carcinogenicity Assessment of Daprodustat (GSK1278863), a Hypoxia-Inducible Factor (HIF)-Prolyl Hydroxylase Inhibitor.
Toxicol Pathol
; 48(2): 362-378, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31640478
2.
Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1-34).
Regul Toxicol Pharmacol
; 86: 356-365, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28389324
3.
Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study.
Regul Toxicol Pharmacol
; 81: 212-222, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27569204
4.
Decreased osteoprogenitor proliferation precedes attenuation of cancellous bone formation in ovariectomized rats treated with sclerostin antibody.
Bone Rep
; 8: 90-94, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29955626
5.
Evaluation of Infrared Thermometry in Cynomolgus Macaques (Macaca fascicularis).
J Am Assoc Lab Anim Sci
; 56(1): 84-89, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28905720
6.
Romosozumab Improves Bone Mass and Strength While Maintaining Bone Quality in Ovariectomized Cynomolgus Monkeys.
J Bone Miner Res
; 32(4): 788-801, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27865001